These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24182219)

  • 81. Questions Swirl Around Screening for Multiple Cancers With a Single Blood Test.
    Rubin R
    JAMA; 2024 Apr; 331(13):1077-1080. PubMed ID: 38488817
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The continuum of screening and early detection, awareness and faster diagnosis of lung cancer.
    Peake MD; Navani N; Baldwin DR
    Thorax; 2018 Dec; 73(12):1097-1098. PubMed ID: 30097536
    [No Abstract]   [Full Text] [Related]  

  • 83. Downstaging is more important than screening for asymptomatic breast cancer.
    Yip CH
    Lancet Glob Health; 2019 Jun; 7(6):e690-e691. PubMed ID: 31097267
    [No Abstract]   [Full Text] [Related]  

  • 84. The elusive diagnosis of cancer: testing times.
    Nicholson BD; Perera R; Thompson MJ
    Br J Gen Pract; 2018 Nov; 68(676):510-511. PubMed ID: 30361301
    [No Abstract]   [Full Text] [Related]  

  • 85. Response to Lehrer and Rheinstein.
    Fedewa SA; Ma J; Jemal A
    J Natl Cancer Inst; 2020 Oct; 112(10):1069-1070. PubMed ID: 32602890
    [No Abstract]   [Full Text] [Related]  

  • 86. [Not Available].
    Nordström T; Eklund M
    Lakartidningen; 2022 Jan; 119():. PubMed ID: 35019147
    [No Abstract]   [Full Text] [Related]  

  • 87. Metabolic management of advanced prostatic cancer.
    HERBST WP
    AMA Arch Surg; 1952 Jun; 64(6):828-34. PubMed ID: 14923106
    [No Abstract]   [Full Text] [Related]  

  • 88. [Specification for service of cancers screening for workers (T/CHAA 023-2023)].
    Chinese Health Association
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):473-485. PubMed ID: 38678341
    [No Abstract]   [Full Text] [Related]  

  • 89. Carcinoma of the prostate with an evaluation of its present day management.
    BIRDSALL JC
    J Urol; 1948 Feb; 59(2):220-8. PubMed ID: 18902184
    [No Abstract]   [Full Text] [Related]  

  • 90. [Not Available].
    Bratt O
    Lakartidningen; 2023 Aug; 120():. PubMed ID: 37606003
    [No Abstract]   [Full Text] [Related]  

  • 91. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 92. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
    Rodriguez JF; Eggener SE
    Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prostate cancer screening.
    Faigen M
    Med J Aust; 2013 Nov; 199(9):585. PubMed ID: 24182219
    [No Abstract]   [Full Text] [Related]  

  • 94. Antibiotic resistance and transrectal prostate biopsies.
    Davies RJ; Stephenson BM; Llewelyn M; Carter AC; Kubiak E
    BMJ; 2013 Feb; 346():f1171. PubMed ID: 23444435
    [No Abstract]   [Full Text] [Related]  

  • 95. Prostate cancer screening and the management of clinically localized disease.
    Wilt TJ; Ahmed HU
    BMJ; 2013 Jan; 346():f325. PubMed ID: 23360718
    [No Abstract]   [Full Text] [Related]  

  • 96. [Prostate cancer screening].
    Rodríguez-Carlin A; Castillo O
    Medwave; 2016 Jul; 16(6):e6504. PubMed ID: 27532121
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.